You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Combining Immunotherapy and Radiation Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Carcinoma of Unknown Primary, Locally Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Laryngeal

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +5 more
  • External Beam Radiation Therapy
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 1, 2022

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Not yet recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +10 more
  • (no location specified)
Jan 31, 2023

Pleural Mesothelioma Trial in Rochester (Immunotherapy, Quality-of-Life Assessment, Stereotactic Body Radiation Therapy)

Recruiting
  • Pleural Mesothelioma
  • Immunotherapy
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Mycosis Fungoides Trial (Imiquimod, Radiation Therapy)

Not yet recruiting
  • Mycosis Fungoides
  • (no location specified)
Apr 29, 2023

Hematopoietic and Lymphoid Cell Tumor, Metastatic Malignant Solid Tumor Trial in United States (External Beam Radiation Therapy,

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • External Beam Radiation Therapy
  • +2 more
  • Conroe, Texas
  • +4 more
Dec 12, 2022

Lung Cancer, Non-small Cell Trial in Nanjing (hypofractionated radiation therapy)

Active, not recruiting
  • Lung Cancer, Non-small Cell
  • hypofractionated radiation therapy
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Mar 13, 2023

Stage IV NSCLC Trial in Palo Alto (Immunotherapy (physician's choice for standard of care immunotherapy), Image-guided Radiation

Active, not recruiting
  • Stage IV Non-Small Cell Lung Cancer
  • Immunotherapy (physician's choice for standard of care immunotherapy)
  • Image-guided Radiation Therapy
  • Palo Alto, California
    Stanford University, School of Medicine
Aug 17, 2022

Prostate Cancer, Prostate Disease Trial in Tampa (Nivolumab, Brachytherapy, External Beam Radiation Therapy)

Recruiting
  • Prostate Cancer
  • Prostate Disease
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 11, 2022

Melanoma Trial in Houston (Immunotherapy, Quality-of-Life Assessment, Radiation Therapy)

Recruiting
  • Melanoma
  • Immunotherapy
  • +2 more
  • Camden, New Jersey
  • +1 more
Nov 11, 2022

Omitting Clinical Target Volume in Radical Treatment of

Not yet recruiting
  • Immunotherapy
  • +3 more
  • IMRT+adjuvant immunotherapy
  • (no location specified)
Jun 9, 2023

Chemo, Radiation Therapy Trial in Fuzhou (Camrelizumab, Paclitaxel, Cisplatin)

Not yet recruiting
  • Chemotherapy
  • Radiation Therapy
  • Fuzhou, China
    Fujian Medical University Union Hospital
Apr 6, 2023

NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in Lexington (Immune checkpoint inhibitor, Radiation Therapy)

Recruiting
  • Non-small Cell Lung Cancer
  • Squamous Cell Carcinoma of the Head and Neck
  • Immune checkpoint inhibitor
  • Radiation Therapy
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Nov 10, 2022

Melanoma Trial in Rochester (Nivolumab, Pembrolizumab, Radiation Therapy)

Recruiting
  • Melanoma
  • Nivolumab
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 5, 2022

Non Small Cell Lung Cancer Metastatic Trial in Morgantown (Radiation, Immuno-Therapeutic Agent)

Active, not recruiting
  • Non Small Cell Lung Cancer Metastatic
  • Radiation
  • Immuno-Therapeutic Agent
  • Morgantown, West Virginia
    WVU Cancer Institute - Mary Babb Randolph Cancer Center
Apr 25, 2022

Urinary Bladder Cancer Trial in München, Ulm, Würzburg (drug, radiation, procedure)

Active, not recruiting
  • Urinary Bladder Cancer
  • München, Germany
  • +2 more
Oct 19, 2022

Breast Cancer, Triple Negative Breast Cancer Trial in Washington, Boston, Chapel Hill (Niraparib, Dostarlimab, Radiation

Recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Washington, District of Columbia
  • +2 more
Apr 13, 2022

TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial (Pembrolizumab, Radiation Therapy, Axatilimab)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Breast Cancer
  • (no location specified)
Aug 4, 2022

Proton SBRT and Immunotherapy for Recurrent/Progressive

Terminated
  • Head and Neck Cancer
  • Proton Stereotactic Body Radiation Therapy (SBRT) (5 fractions; 3500-4500 cGy)
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Aug 31, 2022

Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Rochester (Durvalumab, Radiation Therapy)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • Stage III Lung Cancer AJCC v8
  • Durvalumab
  • Radiation Therapy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Esophageal Squamous Cell Carcinoma, Oligometastatic Disease Trial in Guangzhou (PD-1 combined with SBRT)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Oligometastatic Disease
  • PD-1 combined with SBRT
  • Guangzhou, Guangdong, China
    Mian Xi
Dec 18, 2022

Metastatic Cancer Trial in La Jolla (CBI, CBI plus SBRT)

Active, not recruiting
  • Metastatic Cancer
  • La Jolla, California
    UCSD Moores Cancer Center
May 16, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 2, 2022

Small-cell Lung Cancer Trial in New York (Carboplatin, Etoposide, Atezolizumab)

Recruiting
  • Small-cell Lung Cancer
  • New York, New York
    Columbia University Irving Medical Center, Herbert Irving Compre
Apr 7, 2022

Head and Neck Tumors Trial in Detroit (Pembrolizumab 25 MG/1 ML Intravenous Solution [KEYTRUDA])

Recruiting
  • Head and Neck Neoplasms
  • Pembrolizumab 25 MG/1 ML Intravenous Solution [KEYTRUDA]
  • Detroit, Michigan
    Henry Ford Health System
Dec 19, 2022

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Unresectable Breast Carcinoma Trial in Aurora (Nab-paclitaxel,

Withdrawn
  • Triple Negative Breast Cancer
  • +4 more
  • Aurora, Colorado
    University of Colorado Hospital
Dec 2, 2022